Central Retinal Vein Occlusion
RareOphthalmology
Central Retinal Vein Occlusion is treated with 1 medication in our database, including DoubleDex Kit. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Virtus. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Central Retinal Vein Occlusion treatment below.
What help exists for Central Retinal Vein Occlusion
2
drugs indexed
1
with copay cards
1
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Central Retinal Vein Occlusion
2 totalDoubleDex Kit
Dexamethasone Sodium Phosphate, Povidine Iodine · Virtus Pharmaceuticals
OZURDEX
dexamethasone · Allergan
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Central Retinal Vein Occlusion drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Central Retinal Vein Occlusion is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →